EIG
DGX icon

EdgePoint Investment Group’s Quest Diagnostics DGX Stock Holding History

EdgePoint Investment Group’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$476M Buy
2,247,568
+3,699
+0.2% +$726K 3.6% 14
2026
Q1 		$440M Buy
2,243,869
+582,797
+35% +$113M 3.53% 13
2025
Q4 		$288M Buy
1,661,072
+811,320
+95% +$148M 2.37% 15
2025
Q3 		$162M Buy
849,752
+848,481
+66,757% +$151M 1.21% 21
2025
Q2 		$228K Buy
+1,271
New +$221K ﹤0.01% 39

Other funds holding DGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

EdgePoint Investment Group's DGX Position: Q2 2026 in Review

EdgePoint Investment Group increased its Quest Diagnostics (DGX) stake by 0.16% in Q2 2026, buying an estimated $726K and bringing the position to 2,247,568 shares worth $476M. The position accounts for 3.6% of the portfolio, ranked #14.

EdgePoint Investment Group first reported a position in DGX in Q2 2025 and has held it in 5 quarters since. 1,106 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • EdgePoint Investment Group held 2,247,568 shares of Quest Diagnostics worth $476M as of Q2 2026.
  • EdgePoint Investment Group bought 3,699 Quest Diagnostics shares in Q2 2026, an estimated $726K.
  • Quest Diagnostics made up 3.6% of EdgePoint Investment Group's portfolio in Q2 2026, its #14 holding.
  • EdgePoint Investment Group first reported a position in Quest Diagnostics in Q2 2025 and has held it in 5 quarters since.
  • 1,106 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on EdgePoint Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.